Qps Bioserve

Hyderabad, India
Offers end-to-end contract research services focused on the generic pharmaceutical industry.

About Qps Bioserve

Qps Bioserve is a Healthcare company based in Hyderabad (India). It offers end-to-end contract research services focused on the generic pharmaceutical industry. It operates on a B2B model. The company has 167 employees. Its Indian entity Qps Bioserve India Private Limited reported revenue of β‚Ή78.02 Cr. Its focus areas include Healthcare and Pharmaceuticals, Pharmaceuticals, Contract Research and Generic Drug Services.

Company details

Qps Bioserve offers end-to-end contract research services focused on the generic pharmaceutical industry, focusing on healthcare and pharmaceuticals, producing pharmaceutical products, contract research, and generic drug services. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Key Metrics
  • Annual Revenue
    ₹78.02 Cr

    FY 2025 · +11% YoY

  • Net Profit
    ₹23.10 Cr

    FY 2025 · 30% margin

  • EBITDA
    ₹34.11 Cr

    FY 2025 · 44% margin

  • Employee Count
    167

Board of directors of Qps Bioserve India Private Limited (Qps Bioserve)

Qps Bioserve India Private Limited is the primary company behind Qps Bioserve. The board of Qps Bioserve India Private Limited currently have 3 directors; the longest-serving is Benjamin Mingta Chien, appointed in 2011. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Benjamin Mingta Chien
DIN 03369370
Nominee Director11 Mar 201115 yrs 7 moQps Bioserve India Private Limited
Chang Jen Yen
DIN 03375333
Nominee Director11 Mar 201115 yrs 7 moQps Bioserve India Private Limited
Kumar Ramu
DIN 03374776
Nominee Director11 Mar 201115 yrs 7 moQps Bioserve India Private Limited

Financials of Qps Bioserve

Figures of Qps Bioserve India Private Limited, the primary company behind Qps Bioserve, for FY 2025. Revenue was ₹78.02 Cr (+11% year on year). Net profit was ₹23.10 Cr (30% margin). EBITDA was ₹34.11 Cr (44% margin). Revenue has grown at a compounded annual rate of 0% over three years and +16% over five years.

  • ₹78.02 CrRevenue · FY 2025 · +11% YoY
  • ₹23.10 CrNet profit · 30% margin
  • ₹34.11 CrEBITDA · 44% margin
  • ₹3.88 CrPaid-up capital
  • 167Employees (provident fund records)
  • 0%Revenue CAGR, 3 years
  • +16%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Qps Bioserve India Private Limited are on its company page.

Premium access

Detailed financial statements for Qps Bioserve

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Qps Bioserve

Premium access

Complete news archive for Qps Bioserve

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Qps Bioserve

Qps Bioserve is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Qps Bioserve has 167 employees.

The primary company behind Qps Bioserve, Qps Bioserve India Private Limited, reported revenue of β‚Ή78.02 Cr for FY 2025, up 11% year on year.

Qps Bioserve offers end-to-end contract research services focused on the generic pharmaceutical industry, focusing on healthcare and pharmaceuticals, producing pharmaceutical products, contract research, and generic drug services. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Qps Bioserve operates through Qps Bioserve India Private Limited.

The legal entities of Qps Bioserve currently have 3 directors, including Benjamin Mingta Chien, Chang Jen Yen, Kumar Ramu.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available